GeneExcel is engaged in the R&D and deployment of liposome technologies for the treatment of cancer, HIV, and cardiovascular diseases.
GeneExcel engages in the discovery, design, development, and deployment of liposome technologies. Its technologies are utilized for the treatment of cancer, cardiovascular diseases, and HIV-1-related diseases. The company also provides contract manufacturing services for customized systemic liposome products. Gene Excel was founded in 2002 and is based in Houston, Texas.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 15, 2005 | Series A | $700K | 1 | ITX International Holdings | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
ITX International Holdings | Yes | Series A |